Purpose Chronic inflammatory processes contribute to the pathogenesis of many age-related diseases. In search of anti-inflammatory foods, we have systematically screened a variety of common dietary plants and mushrooms for their anti-inflammatory activity. Methods A selection of 115 samples was prepared by a generic food-compatible processing method involving heating. These products were tested for their anti-inflammatory activity in murine N11 microglia and RAW 264.7 macrophages, using nitric oxide (NO) and tumour necrosis factor-a (TNF-a) as pro-inflammatory readouts. Results Ten food samples including lime zest, English breakfast tea, honey-brown mushroom, button mushroom, oyster mushroom, cinnamon and cloves inhibited NO production in N11 microglia, with IC 50 values below 0.5 mg/ml. The most active samples were onion, oregano and red sweet potato, exhibiting IC 50 values below 0.1 mg/ml. When these ten food preparations were retested in RAW 264.7 macrophages, they all inhibited NO production similar to the results obtained in N11 microglia. In addition, English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom preparations suppressed TNF-a production, exhibiting IC 50 values below 0.5 mg/ml in RAW 264.7 macrophages. Conclusion In summary, anti-inflammatory activity in these food samples survived 'cooking'. Provided that individual bioavailability allows active compounds to reach therapeutic levels in target tissues, these foods may be useful in limiting inflammation in a variety of agerelated inflammatory diseases. Furthermore, these foods could be a source for the discovery of novel anti-inflammatory drugs.
Introduction
The increase in both the absolute number and relative proportion of the elderly is arguably one of the most important developments facing human society in the next decades [1] . Age is the leading risk factor for many devastating diseases such as acute and chronic neurodegenerative diseases, degenerative musculoskeletal diseases, cardiovascular diseases, diabetes, asthma, rheumatoid arthritis and inflammatory bowel disease. Increasing evidence suggests that systemic low-grade inflammation is a contributing factor in these age-related diseases [2] [3] [4] [5] [6] . To date, pharmacotherapy of inflammatory conditions is based on the use of non-steroidal anti-inflammatory drugs (NSAIDs). However, NSAIDs can cause serious gastrointestinal toxicity such as gastric bleeding and the formation of stomach ulcers [7, 8] . Even more ominously, some NSAIDs, particularly COX-2 inhibitors, have been linked to increased blood pressure, greatly increased risk of congestive heart failure, occurrence of thrombosis and myocardial infarction [9] [10] [11] . Together, these findings provide the motivation for the development of anti-inflammatory treatments with fewer adverse effects.
Herbal medicines derived from plants rich in the secondary metabolite salicylic acid, such as the bark of the willow tree (Salix alba), have been used for the treatment for diseases with a prominent inflammatory component for thousands of years. Many other medicinal plants are known to have anti-inflammatory activity, but neither the underlying mechanisms nor their potential for the development of new drugs has been fully explored. Several mechanisms are proposed to explain their anti-inflammatory action, including inhibition of cyclooxygenases and lipoxygenases or modulation of pro-inflammatory gene expression such as inducible nitric oxide synthase, and several pivotal cytokines including tumour necrosis factor-a (TNF-a) [12, 13] .
However, very few studies have attempted a systematic comparison of a large number of commercially available plant and mushroom foods in search of those with the highest degree of anti-inflammatory activities. To close this knowledge gap, we have screened 115 dietary plants and mushrooms for in vitro anti-inflammatory activities using a generic food-compatible sample processing method involving heating in water or in the presence of glucose.
Materials and methods

Materials
Plant and mushroom samples in the screening library were obtained from retail suppliers in Melbourne, Australia. DMSO, 95 % ethanol, bovine serum albumin, lipopolysaccharide (LPS) (Escherichia coli serotype 0127:B8), EDTA, N-(1-1-napthyl) ethylenediaminedihydrochloride, penicillin G sodium benzyl, resazurin sodium, streptomycin, sulphanilamide, tetramethylbenzidine (TMB) and trypan blue were purchased from Sigma-Aldrich (Castle Hill, NWS, Australia). Antibiotics, Dulbecco's modified Eagle's medium (DMEM), foetal bovine serum (FBS) and glutamine were purchased from Invitrogen (Mulgrave, Vic, Australia). Murine IFN-c and TNF-a ELISA kits were purchased from Peprotech (Rocky Hill, NJ, USA).
Methods
Preparation of the food and plant library samples
Plant and mushroom library samples were prepared by methods usually employed with food preparation, involving heating (i.e. 'cooking'), mechanical dispersion and treatments intended to solubilise both hydrophobic and hydrophilic solutes. Samples were prepared by blending in a food processor with water (1:2 ratio w/v) before heating in a microwave for 10 min under control conditions or including 1 % glucose, to enhance Maillard reaction products. After cooling to room temperature, ascorbic acid (0.1 % of initial solids) and ethanol (1 % of initial solids) were added for microbial stabilisation. Samples were ultrasonicated using a 400-W probe at 100 % power for 2 min (Hielscher 400UPS) before freeze drying.
Maintenance of N11 microglia and RAW 264.7 macrophages
Cells were cultured in 175-cm 2 flasks in DMEM containing 5 % FBS, supplemented with glutamine (2 mM), penicillin (200 U/ml), streptomycin (200 lg/ml) and fungizone (2.6 lg/ml). The cell lines were maintained in 5 % CO 2 at 37°C.
Pro-inflammatory activation of cells
Cells were seeded at a density of 75,000/well into each well of a 96-well plate. After 24 h, a combination of 25 lg/ml LPS and 10 U/ml IFN-c diluted in DMEM was used for activation. The food samples were dissolved in DMEM, and insoluble solids were removed by centrifugation at 16,9009g for 2 min. Samples were added to the cells an hour prior to the addition of the inflammatory activation mix at a maximal concentration of 2.5 mg/ml, from which 6 doses were made by serial 1:2 dilutions. Cells were incubated for 24 h at 37°C with the inflammatory activation mix before NO and TNF-a levels were measured.
Measurement of nitrite levels by the Griess assay
NO release was measured through the quantification of nitrite by the Griess assay. The Griess reagent was made up of equal volumes of 1 % sulphanilamide and 0.1 % napthyl ethylenediamine in 5 % HCl. From each well, 80 ll of cell culture medium was transferred to a fresh 96-well plate and mixed with 80 ll of Griess reagent, and after 30 min at room temperature, absorbance was measured at 540 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington, Australia) and expressed as a percentage of that in control cells.
Measurement of TNF-a levels by enzyme-linked immunosorbent assay (ELISA)
Determination of TNF-a was performed by ELISA, according to the manufacturer's instructions (Peprotech) with minor modifications. Briefly, the capture antibody was diluted to 0.5 lg/ml in phosphate-buffered saline (PBS; 1.9 mM NaH 2 PO4, 8.1 mM Na 2 HPO4, 154 mM NaCl pH 7.4), and 100 ll of diluted capture antibody was added to each well of a 96-well plate, sealed with parafilm and incubated overnight at room temperature. The plate was washed 4 times with washing buffer (0.05 % Tween-20 in PBS), 250 ll of blocking buffer (1 % BSA in PBS) was added to each well, and the plate was covered and incubated for 1 h at room temperature. The plate was again washed 4 times in washing buffer. TNF-a standard was serially diluted from 0 to 10,000 pg/ml in diluent (0.05 % Tween-20, 0.1 % BSA in PBS). To each well, 50 ll of cell supernatant or TNF-a standard in duplicate was added; the plate was covered and incubated for 2.5 h at room temperature. Each well was washed 4 times with washing buffer. Detection antibody was diluted to 0.125 lg/ml in diluent (supplied by the manufacturer), and 100 ll of diluted detection antibody was added to each well. The plate was covered and incubated for 2.5 h before being washed 4 times with washing buffer. Avidin-peroxidase conjugate was diluted to a ratio of 1:4,000 in diluent, and 100 ll of diluted Avidin-peroxidase conjugate solution was added to each well; the plate was covered and incubated for 30 min before being washed 4 times with washing buffer. To each well, 100 ll of 3,3 0 ,5,5 0 -tetramethylbenzidine (TMB) liquid substrate solution (0.5 mg TMB dissolved in 1 ml DMSO, supplemented with 9 ml phosphate-citrate buffer and 1 ll 30 % H 2 O 2 ) was added. Absorbance was measured at 655 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington, Australia), taking readings every 5 min. After 25 min, the reaction was stopped using 0.5 M sulphuric acid, and then the absorbance was measured at a wavelength of 455 nm.
Determination of cell viability
The Alamar Blue assay is a colorimetric assay involving the cellular reduction of resazurin to resorufin. Resazurin was dissolved in PBS to give a concentration of 0.001 % (w/v), sterile-filtered (0.22 lm), protected from light with aluminium foil and stored at 4°C for up to 6 months. To determine cell viability, incubation media were aspirated from wells and replaced with 100 ll of resazurin solution and incubated at 37°C for 1 h. After incubation for 1 h, fluorescence of formed resorufin was measured with excitation at 530 nm and emission at 590 nm in a POLARstar Omega microplate reader (BMG Labtech, Mornington, Australia) and expressed as a percentage of that in control cells, after background fluorescence was subtracted.
Data calculation and statistics
Data calculations were performed using MS Excel 2010 software. IC 50 values were obtained by using the sigmoidal dose-response function in GraphPad Prism. IC 50 values from three experiments were averaged (all performed in triplicate). The results were expressed as mean ± standard deviation. Differences between the same sample heated in water or glucose were analysed by t-tests using GraphPad Prism.
Results
Primary screen of 115 food and mushroom samples using nitric oxide as pro-inflammatory readout A total of 115 commercially available dietary plants and mushrooms were selected (Table 1) . Samples were prepared using a generic food-compatible sample processing method involving heating in water or in the presence of 1 % glucose (to allow modification by the Maillard reaction to form Maillard reaction products, MRPs).
These 115 samples (including 115 identical samples heated with glucose) were then tested for their ability to down-regulate LPS ? IFN-c-induced NO production in N11 microglia (Table 1) . Ten food preparations demonstrated significant anti-inflammatory activity, with IC 50 values below 0.5 mg/ml ( Table 2) . Seven of these food preparations, including lime zest, English breakfast tea, honey-brown mushroom, button mushroom, oyster mushroom, cinnamon and cloves, demonstrated potent anti-inflammatory activity, with IC 50 values between 0.1 and 0.5 mg/ml (Table 2 ). However, the most active food samples were onion, followed by oregano and red sweet potato, exhibiting IC 50 values below 0.1 mg/ml (Table 3) . Furthermore, the MRP-modified samples showed IC 50 values in the same order of magnitude as the unmodified samples, and despite significant differences in some samples between the unmodified and MRP-modified samples, no general increase in anti-inflammatory activity by the inclusion of glucose in the heating mixture could be detected. All of the active preparations were non-toxic at the IC 50 values (cell viability [75 %), suggesting that the reduction in NO production was not simply caused by a decrease in cell number or cell viability.
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The 10 most active samples (defined as having an IC 50 value of \0.5 or 0.1 mg/ml, respectively) with demonstrated anti-inflammatory properties from the primary screen were retested in a second cell line with an additional pro-inflammatory readout, TNF-a. Since the previous experiment did not show any striking difference between the original and glucose-modified preparations, no glucosemodified samples were used in the second screen, except for lime zest, where the availability of the unmodified sample was limited. These 10 active samples (English breakfast tea leaves, onion, oregano, oyster mushroom, red sweet potato, lime zest, honey-brown mushroom, button mushroom, cinnamon and cloves) were tested by measuring their ability to down-regulate LPS ? IFN-c-induced release of NO and, as a second marker of inflammation, TNF-a (Table 4) .
Of the 10 products, oyster mushroom and cinnamon demonstrated the most significant anti-inflammatory activities (with IC 50 values below 0.1 mg/ml), followed by cloves, oregano, onion, English breakfast tea leaves and lime zest (with IC 50 values below 0.5 mg/ml) in terms of suppression of LPS-and IFN-c-induced NO production. In addition, English breakfast tea leaves, oyster mushroom, onion, cinnamon and button mushroom preparations also suppressed TNF-a release (with IC 50 values below 0.5 mg/ml). Oyster mushroom was the most active anti-inflammatory sample for both NO inhibition and TNF-a inhibition, with IC 50 values 0.067 and 0.23 mg/ml, respectively (Table 4) .
In addition, two anti-inflammatory drugs, including prednisone and the non-steroidal anti-inflammatory drug (NSAID) ibuprofen, were tested in the same assay systems. Ibuprofen was toxic to cells at concentrations of 1.63 ± 0.44 mM, and NO and TNF-a production were down-regulated at the same concentrations (Table 4) . Prednisone inhibited LPS ? IFN-c-induced NO and TNF-a production, with IC 50 values of 0.25 ± 0.09 mg/ml (0.69 ± 0.26 mM) and 0.7 ± 0.07 mg/ml (1.95 ± 0.21 mM), respectively (Table 4) .
Discussion
The activation of macrophages and microglia leads to secretion of inflammatory molecules such as the proinflammatory cytokine TNF-a and the free radical NO, which play an important role in inflammation and nitroxidative stress in many age-related diseases, including Alzheimer's disease (AD) [14] . In the assay systems used here, the bacterial surface molecule lipopolysaccharide and the cytokine IFN-c were used to activate microglia, and NO and TNF-a release were used as readouts [15] .
As control substances, the synthetic corticosteroid prednisone and the non-steroidal anti-inflammatory drug (NSAID) ibuprofen were also tested in the same assay systems. As expected, ibuprofen as a selective COX-1 and COX-2 inhibitor did not specifically inhibit LPS-and IFNc-induced NO and TNF-c production. Interestingly, prednisone was quite a weak inhibitor of LPS ? IFN-c-induced NO and TNF-a production, since in many other inflammatory paradigms, corticosteroids are effective at low micromolar, and in some instances at nanomolar, concentrations [13] . However, it appears that macrophages treated with a combination of LPS and IFN-c (compared to LPS alone) are insensitive to anti-inflammatory corticosteroids such as dexamethasone [14, 15] , which is consistent with our observations. Among the food samples, one hundred and fifteen distinct plants and mushroom preparations were screened for anti-inflammatory properties by employing in vitro cellbased bioassays. The extracts of several plants including onion, oregano, red sweet potato, lime zest, cinnamon and cloves exhibited the strongest capacity to suppress NO and TNF-a. Interestingly, oyster mushroom, honey-brown mushroom and button mushroom also showed significant anti-inflammatory potential.
Interestingly, a differential effect of MRP modification on the activity of the food preparations was observed, depending on the sample. Since high molecular MRPs (also termed advanced glycation end products, AGEs) are known to increase inflammation [16, 17] and low molecular MRPs (MW \ 1 kDa) have been shown to possess anti-inflammatory potential [18] , it might be the balance between these species that shift the IC 50 value up or down depending on the composition of the sample. Some of our data are in accordance with published studies on anti-inflammatory properties of the foods identified as potent in this study. For example, onions have been shown to exhibit anti-inflammatory properties, for example down-regulation of adipokine expression in the visceral adipose tissue of rats or attenuation of vascular inflammation and oxidative stress in fructose-fed rats [19, 20] . Among the polyphenols in onions, quercetin was suggested to be the responsible anti-inflammatory ingredient, as evidenced by the down-regulation of COX2 transcription in human lymphocytes [21] . Furthermore, the anti-inflammatory activity of the onion has been studied also in relation to the presence of thiosulphinates and cepaenes [22, 23] .
Anti-inflammatory properties of cinnamon have been demonstrated for Cinnamomum osmophloeum kaneh [24, 25] , but less is known about the 'true' cinnamon of India, Cinnamomum zeylanicum. Some authors reported significant inhibitory effects of inflammatory signalling by the extracts of C. cassia [26] . Sodium benzoate appears to be one of the active ingredients in cinnamon, since it inhibits LPS-induced expression of inducible NO synthase (iNOS), pro-inflammatory cytokines (TNF-a and IL-1b) and surface markers for inflammatory activation such as CD11b, CD11c and CD68 in mouse microglia [27] .
Clove (Syzygium aromaticum) extracts have been identified as having potent free radical (including superoxide anion) scavenging properties and metal chelating activities, which may be due to the presence of flavonoids. Cloves contain considerable concentrations of eugenol, beta-caryophyllene, quercetin and kaempferol as well as rhamnetin and kaempferol and their glycosides [28] . Our study is in line with studies showing that eugenol suppresses NF-jB activation, thereby down-regulating cyclooxygenase-2 expression in lipopolysaccharide-stimulated macrophages [29] [30] [31] .
Red sweet potato (Ipomoea batatas), a species rich in b-carotene and anthocyanins [32] , has been demonstrated to have anti-inflammatory properties for the first time by our study. Lime (Citrus aurantifolia) rich in flavonol glycosides, especially of kaempferol-type, is known for their antioxidant properties [33] ; however, our study is also the first to report on its anti-inflammatory activities.
The anti-inflammatory properties of the various mushroom species were quite surprising, since there are only a handful studies showing such activity. For example, oyster mushroom concentrate (OMC) was shown to suppress LPS-induced secretion of TNF-a, IL-6 and IL-12p40 in RAW 264.7 macrophages and also suppressed PGE2 and NO by down-regulation of COX-2 and iNOS expression, respectively. OMC also inhibited LPS-dependent DNA binding activity of AP-1 and NF-jB in RAW 264.7 cells [34] . Our results correlate with these observations as oyster mushroom extracts inhibited LPS ? IFN-c-induced production of NO. In mushrooms, water-soluble polysaccharides, especially the b-glucans, are most likely to be the substances responsible for the anti-inflammatory properties. For example, b-glucans isolated from Pleurotus ostreatus were able to potentiate the anti-inflammatory effects of methotrexate in rat models of experimental arthritis or colitis [35, 36] . A further potential antiinflammatory compound in mushrooms could be ergothioneine (ET), a sulphur-containing amino acid that functions as an antioxidant and is present in mushrooms at a concentration of up to 2.0 mg/g [37] . In acute respiratory distress syndrome (ARDS), ergothioneine given intravenously 1 h before or 18 h after cytokine (IL-1 and IFN-c) insufflation decreased lung injury and lung inflammation in cytokine-insufflated rats [38] .
In summary, it is suggested that foods having antiinflammatory properties might be useful in the prevention of age-related inflammatory conditions, provided that dose and individual bioavailability lead to therapeutic concentrations in affected tissues. Bioavailability of plant substances including polyphenols is highly variable and will depend on the nature of the compound [39, 40] . Therefore, validation of the active samples in animal models should eventually follow. Furthermore, we speculate that these natural sources could lead to the discovery of potent novel anti-inflammatory compounds.
